Lead sulfide nanoparticles were manufactured from lead oxide using a procedure described in the Ayurveda formulary of India, which involved using a quantum of the heat of up to 60 puta, which is officially known as the Shasti puta Naga Bhasma.
Objective
The study shows sulfurization of nanoparticles significantly decreased their toxicity due to the lower solubility.
Materials and Methods
The present work used the arsenic sulfide media and traditional puta for processing and the characterization of the same has been conducted. Different analytical techniques like X-ray diffraction (XRD), scanning electron microscopy (SEM), energy-dispersive X-Ray (EDX) spectroscopy, Fourier transform infrared spectroscopy (FTIR), and thermo-gravimetry analysis (TGA) were used.The study shows sulfurization of nanoparticles significantly decreased their toxicity due to the lower solubility. Materials and Methods: The present work used the arsenic sulfide media and traditional puta for Naga bhasma processing and the characterization of the same has been conducted. Different analytical techniques like X-ray diffraction (XRD), scanning electron microscopy (SEM), energy-dispersive X-Ray (EDX) spectroscopy, Fourier transform infrared spectroscopy (FTIR), and thermo-gravimetry analysis (TGA) were used.
Results
Powder x-ray diffraction, scanning electron microscopy, Fourier transform infrared spectroscopy, Thermogravimetric analysis, and differential thermal analysis all showed that the produced nanoparticles are lead sulfide nanoparticles with a particle size of an average of 84.60 and the crystalline average size of 69.06 nm.
Conclusion
The rounded, rod, oval, cubic, and circular morphology of the produced lead sulfide nanoparticles can be seen in the SEM image. The stretching and bending functional groups in the sample were alkanes, alkenes, aromatic hydrocarbons, aromatic hydrocarbons, carboxylic acids, alkyl carboxylic acids, alkyl alpha, beta-unsaturated, aldehydes, ketones, carboxylic acid, aliphatic amines, primary amines, secondary amines, alkyl halides, alkyl halides are studied through the FTIR spectrum.
背景使用印度阿育吠陀配方中描述的程序从氧化铅中制造出硫化铅纳米粒子,该程序涉及使用高达 60 puta 的热量,正式名称为 Shasti puta Naga Bhasma.Objective研究表明,由于溶解度较低,纳米粒子的硫化可显著降低其毒性。使用了不同的分析技术,如 X 射线衍射 (XRD)、扫描电子显微镜 (SEM)、能量色散 X 射线 (EDX) 光谱、傅立叶变换红外光谱 (FTIR) 和热重分析 (TGA)。材料和方法:本研究使用硫化砷介质和传统的 puta 来加工 Naga bhasma,并对其进行了表征。使用了不同的分析技术,如 X 射线衍射(XRD)、扫描电子显微镜(SEM)、能量色散 X 射线(EDX)光谱、傅立叶变换红外光谱(FTIR)和热重分析(TGA)。结果粉末 X 射线衍射、扫描电子显微镜、傅立叶变换红外光谱、热重分析和差热分析均表明所制备的纳米颗粒为硫化铅纳米颗粒,其平均粒径为 84.60 纳米,结晶平均粒径为 69.06 纳米。通过傅立叶变换红外光谱研究了样品中的伸展和弯曲官能团,包括烷、烯、芳香烃、芳香烃、羧酸、烷基羧酸、烷基α、β-不饱和、醛、酮、羧酸、脂肪族胺、伯胺、仲胺、烷基卤化物、烷基卤化物。
{"title":"Characterization of lead sulfide obtained from Naga Bhasma","authors":"Manoj Kumar Dash , Namrata Joshi , Laxmikant Dwivedi , Vd Sushil Dubey , Kamal Nayan Dwivedi","doi":"10.1016/j.jaim.2023.100864","DOIUrl":"https://doi.org/10.1016/j.jaim.2023.100864","url":null,"abstract":"<div><h3>Background</h3><p>Lead sulfide nanoparticles were manufactured from lead oxide using a procedure described in the Ayurveda formulary of India, which involved using a quantum of the heat of up to 60 puta, which is officially known as the <em>Shasti puta Naga Bhasma</em>.</p></div><div><h3>Objective</h3><p>The study shows sulfurization of nanoparticles significantly decreased their toxicity due to the lower solubility.</p></div><div><h3>Materials and Methods</h3><p>The present work used the arsenic sulfide media and traditional puta for processing and the characterization of the same has been conducted. Different analytical techniques like X-ray diffraction (XRD), scanning electron microscopy (SEM), energy-dispersive X-Ray (EDX) spectroscopy, Fourier transform infrared spectroscopy (FTIR), and thermo-gravimetry analysis (TGA) were used.The study shows sulfurization of nanoparticles significantly decreased their toxicity due to the lower solubility. Materials and Methods: The present work used the arsenic sulfide media and traditional puta for Naga bhasma processing and the characterization of the same has been conducted. Different analytical techniques like X-ray diffraction (XRD), scanning electron microscopy (SEM), energy-dispersive X-Ray (EDX) spectroscopy, Fourier transform infrared spectroscopy (FTIR), and thermo-gravimetry analysis (TGA) were used.</p></div><div><h3>Results</h3><p>Powder x-ray diffraction, scanning electron microscopy, Fourier transform infrared spectroscopy, Thermogravimetric analysis, and differential thermal analysis all showed that the produced nanoparticles are lead sulfide nanoparticles with a particle size of an average of 84.60 and the crystalline average size of 69.06 nm.</p></div><div><h3>Conclusion</h3><p>The rounded, rod, oval, cubic, and circular morphology of the produced lead sulfide nanoparticles can be seen in the SEM image. The stretching and bending functional groups in the sample were alkanes, alkenes, aromatic hydrocarbons, aromatic hydrocarbons, carboxylic acids, alkyl carboxylic acids, alkyl alpha, beta-unsaturated, aldehydes, ketones, carboxylic acid, aliphatic amines, primary amines, secondary amines, alkyl halides, alkyl halides are studied through the FTIR spectrum.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 2","pages":"Article 100864"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S097594762300181X/pdfft?md5=1b9111afc3c7d85e4e72044f5ecb67d0&pid=1-s2.0-S097594762300181X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140195809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.jaim.2024.100905
Rahul Sherkhane , Shruti Singh , Aadithyaraj K T , Anil Kumar , Ashish Sharma , Shiv Ji Gupta
Crush injuries to the foot have become increasingly prevalent in contemporary settings, primarily arising from incidents such as the impact of large objects falling onto the foot or involvement in traffic accidents. The complexity of treating these injuries is compounded by the intricate anatomy of the foot. In specific scenarios, the implementation of an integrated management approach could prove advantageous.
In this report, we depict the case of a 23-year-old male who visited the Shalya OPD with a wound on his left foot caused by trauma. The wound covered the medial portion of the foot, involving the dorsal area, and measured roughly 20 cm by 9 cm and was unable to walk. We successfully managed the case by adopting an integrative approach. The Ayurvedic treatment included Panchavalkala kashaya for wound irrigation, as well as oral administration of Amalaki rasayana, Triphala guggulu, Shatavari churna and Ashwagandha churna. Jatyadi taila was topically applied. For the first seven days, in addition to these ayurvedic medications, we also employed analgesics and antibiotics to treat infection and pain. To accomplish early closure, we employed a split-thickness skin graft after sufficient granulation tissue had appeared.
The wound was completely healed within three months and the patient was able to walk freely without any support. The combined approach yielded a promising result in this case.
{"title":"An integrative approach for management of post-traumatic dorsal foot wounds - A case report","authors":"Rahul Sherkhane , Shruti Singh , Aadithyaraj K T , Anil Kumar , Ashish Sharma , Shiv Ji Gupta","doi":"10.1016/j.jaim.2024.100905","DOIUrl":"https://doi.org/10.1016/j.jaim.2024.100905","url":null,"abstract":"<div><p>Crush injuries to the foot have become increasingly prevalent in contemporary settings, primarily arising from incidents such as the impact of large objects falling onto the foot or involvement in traffic accidents. The complexity of treating these injuries is compounded by the intricate anatomy of the foot. In specific scenarios, the implementation of an integrated management approach could prove advantageous.</p><p>In this report, we depict the case of a 23-year-old male who visited the Shalya OPD with a wound on his left foot caused by trauma. The wound covered the medial portion of the foot, involving the dorsal area, and measured roughly 20 cm by 9 cm and was unable to walk. We successfully managed the case by adopting an integrative approach. The Ayurvedic treatment included <em>Panchavalkala kashaya</em> for wound irrigation, as well as oral administration of <em>Amalaki rasayana, Triphala guggulu</em>, <em>Shatavari churna</em> and <em>Ashwagandha churna</em>. <em>Jatyadi taila</em> was topically applied. For the first seven days, in addition to these ayurvedic medications, we also employed analgesics and antibiotics to treat infection and pain. To accomplish early closure, we employed a split-thickness skin graft after sufficient granulation tissue had appeared.</p><p>The wound was completely healed within three months and the patient was able to walk freely without any support. The combined approach yielded a promising result in this case.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 2","pages":"Article 100905"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000202/pdfft?md5=e9598fd3f6bb8719840d055f598b91ba&pid=1-s2.0-S0975947624000202-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140345091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.jaim.2024.100894
C.K. Saniya, Parvathy G. Nair, P.S. Aswani, A.P. Karthika
{"title":"A critical review of the book ‘Arbuda chikitsa- Ayurvedathile veritta vazhikal’ by Dr. P. B. Susheela Saji","authors":"C.K. Saniya, Parvathy G. Nair, P.S. Aswani, A.P. Karthika","doi":"10.1016/j.jaim.2024.100894","DOIUrl":"https://doi.org/10.1016/j.jaim.2024.100894","url":null,"abstract":"","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 2","pages":"Article 100894"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000093/pdfft?md5=0f3f7bf443a7f328629277d74b1a488a&pid=1-s2.0-S0975947624000093-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140296942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<div><h3>Background</h3><p>Hypertension is a prevalent chronic condition that affects a substantial proportion of the world's population. Medications are commonly prescribed for hypertension management, but non-pharmacological interventions like yoga are gaining popularity.</p></div><div><h3>Objective</h3><p>The purpose of this systematic review and meta-analysis is to assess the efficacy of Yoga Nidra (YN) for the management of hypertension.</p></div><div><h3>Methods</h3><p>A systematic review and meta-analysis of clinical trials, i.e., non-randomized and randomized controlled trials (RCTs) was conducted to investigate the effects of YN on hypertension. PubMed, the Cochrane Library, SCOPUS, and EBSCO were searched for relevant studies published up to September 2022. The quality of the included studies was assessed using the Cochrane risk of bias tool. The primary outcome measure was the change in systolic blood pressure (SBP) and diastolic blood pressure (DBP) after YN intervention, analyzed as weighted mean difference (WMD), in comparison to control groups. The random-effects model was used for the meta-analysis. Risk of bias was assessed for RCTs and non-RCTs using Cochrane's RoB-2 and ROBINS-I tools, respectively.</p></div><div><h3>Results</h3><p>Five RCTs and three Non-RCTs involving a total of 482 participants (239 for YN vs 243 for controls) were included in this review. The meta-analysis indicated that YN significantly reduced SBP (WMD = 12.03 mm Hg, 95% CI [7.12, 16.93], <em>Z</em> = 4.80, <em>p</em> < 0.00001) and DBP (WMD = 6.32 mm Hg, 95% CI [3.53, 9.12], <em>Z</em> = 4.43, <em>p</em> < 0.00001) compared to control groups. The overall risk of bias for the three RCTs was high, whereas for the five non-RCTs, one had an overall moderate risk while the other four had an overall serious risk of bias.</p></div><div><h3>Discussion</h3><p>This systematic review and meta-analysis provides evidence supporting the efficacy of YN as a complementary therapy for hypertension management. YN is a safe, cost-effective, and easily accessible intervention that primarily relies on interoception and induces a deep relaxation response in practitioners, aiding them in coping with various components of high blood pressure, such as stress, vascular inflammation, peripheral vascular resistance, etc. Our understanding of the mechanisms of YN is constantly evolving, and there is a need for further research to fully explore and appreciate the significance of this ancient science and its potential efficacy on BP. Considering the results and the multifactorial role of YN, it can act as a safe and reliable adjuvant therapy to complement the pharmacological treatment of hypertension. However, further studies with larger sample sizes, longer follow-up periods, and homogenous populations are warranted.</p></div><div><h3>Conclusion</h3><p>This meta-analysis suggests that YN is effective in reducing SBP and DBP, particularly in individuals with hypertension. The re
背景高血压是一种普遍存在的慢性疾病,影响着世界上很大一部分人口。本系统综述和荟萃分析的目的是评估瑜伽静坐(Yoga Nidra,YN)对高血压的疗效。方法对临床试验,即非随机和随机对照试验(RCTs)进行了系统综述和荟萃分析,以研究 YN 对高血压的影响。研究人员检索了 PubMed、Cochrane 图书馆、SCOPUS 和 EBSCO 上截至 2022 年 9 月发表的相关研究。使用 Cochrane 偏倚风险工具对纳入研究的质量进行了评估。主要结果指标是 YN 干预后收缩压(SBP)和舒张压(DBP)的变化,以加权平均差(WMD)分析,并与对照组进行比较。荟萃分析采用随机效应模型。采用 Cochrane 的 RoB-2 和 ROBINS-I 工具分别评估了 RCT 和非 RCT 的偏倚风险。荟萃分析表明,与对照组相比,YN 能显著降低 SBP(WMD = 12.03 mm Hg,95% CI [7.12,16.93],Z = 4.80,p < 0.00001)和 DBP(WMD = 6.32 mm Hg,95% CI [3.53,9.12],Z = 4.43,p < 0.00001)。三项研究性试验的总体偏倚风险较高,而五项非研究性试验中,一项研究性试验的总体偏倚风险为中等,其他四项研究性试验的总体偏倚风险为严重。YN是一种安全、具有成本效益且容易获得的干预方法,主要依赖于互感,能诱导练习者产生深度放松反应,帮助他们应对高血压的各种因素,如压力、血管炎症、外周血管阻力等。我们对 YN 机制的认识在不断发展,需要进一步研究,以充分探索和认识这一古老科学的意义及其对血压的潜在疗效。考虑到上述研究结果和云南白药的多因素作用,它可以作为一种安全可靠的辅助疗法,补充高血压的药物治疗。结论这项荟萃分析表明,YN 能有效降低 SBP 和 DBP,尤其是对高血压患者。这些结果凸显了 YN 作为高血压管理辅助疗法的潜力。医疗服务提供者可以考虑向高血压患者推荐 YN,作为药物治疗的辅助疗法。还需要进一步研究,以确定最适合高血压管理的标准化最佳YN形式和持续时间。
{"title":"Yoga Nidra for hypertension: A systematic review and meta-analysis","authors":"Navdeep Ahuja , Praag Bhardwaj , Monika Pathania , Dilasha Sethi , Arjun Kumar , Ashwin Parchani , Akshita Chandel , Aashish Phadke","doi":"10.1016/j.jaim.2023.100882","DOIUrl":"https://doi.org/10.1016/j.jaim.2023.100882","url":null,"abstract":"<div><h3>Background</h3><p>Hypertension is a prevalent chronic condition that affects a substantial proportion of the world's population. Medications are commonly prescribed for hypertension management, but non-pharmacological interventions like yoga are gaining popularity.</p></div><div><h3>Objective</h3><p>The purpose of this systematic review and meta-analysis is to assess the efficacy of Yoga Nidra (YN) for the management of hypertension.</p></div><div><h3>Methods</h3><p>A systematic review and meta-analysis of clinical trials, i.e., non-randomized and randomized controlled trials (RCTs) was conducted to investigate the effects of YN on hypertension. PubMed, the Cochrane Library, SCOPUS, and EBSCO were searched for relevant studies published up to September 2022. The quality of the included studies was assessed using the Cochrane risk of bias tool. The primary outcome measure was the change in systolic blood pressure (SBP) and diastolic blood pressure (DBP) after YN intervention, analyzed as weighted mean difference (WMD), in comparison to control groups. The random-effects model was used for the meta-analysis. Risk of bias was assessed for RCTs and non-RCTs using Cochrane's RoB-2 and ROBINS-I tools, respectively.</p></div><div><h3>Results</h3><p>Five RCTs and three Non-RCTs involving a total of 482 participants (239 for YN vs 243 for controls) were included in this review. The meta-analysis indicated that YN significantly reduced SBP (WMD = 12.03 mm Hg, 95% CI [7.12, 16.93], <em>Z</em> = 4.80, <em>p</em> < 0.00001) and DBP (WMD = 6.32 mm Hg, 95% CI [3.53, 9.12], <em>Z</em> = 4.43, <em>p</em> < 0.00001) compared to control groups. The overall risk of bias for the three RCTs was high, whereas for the five non-RCTs, one had an overall moderate risk while the other four had an overall serious risk of bias.</p></div><div><h3>Discussion</h3><p>This systematic review and meta-analysis provides evidence supporting the efficacy of YN as a complementary therapy for hypertension management. YN is a safe, cost-effective, and easily accessible intervention that primarily relies on interoception and induces a deep relaxation response in practitioners, aiding them in coping with various components of high blood pressure, such as stress, vascular inflammation, peripheral vascular resistance, etc. Our understanding of the mechanisms of YN is constantly evolving, and there is a need for further research to fully explore and appreciate the significance of this ancient science and its potential efficacy on BP. Considering the results and the multifactorial role of YN, it can act as a safe and reliable adjuvant therapy to complement the pharmacological treatment of hypertension. However, further studies with larger sample sizes, longer follow-up periods, and homogenous populations are warranted.</p></div><div><h3>Conclusion</h3><p>This meta-analysis suggests that YN is effective in reducing SBP and DBP, particularly in individuals with hypertension. The re","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 2","pages":"Article 100882"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947623001997/pdfft?md5=2b4d326872a62fe3d67d4288d868a146&pid=1-s2.0-S0975947623001997-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140122039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study reports the successful management of a recurrent, refractory skin disease diagnosed clinically as Cutaneous Lichen Planus (CLP) in a female patient with Ayurvedic treatment. A 42-year-old home maker from Coimbatore presented with blackish-red pigmented skin rashes and white streaks. Though mucous membranes were not affected, she did not respond to homoeopathic and biomedical treatment. The lesions were spread all over the body except for the face, scalp, axillary and genital region. In addition, she complained of dry skin, pain, and itching.
The condition was treated as Kapha-Pitta dominant Tridoshaja Kushta based on Ayurvedic clinical assessment. The patient recovered after one year of conservative Ayurvedic intervention. After six years, there was a relapse, and the patient was admitted for a full course of Ayurvedic treatment and recovered within six months. Ayurvedic interventions should be considered an option in refractory skin diseases like Cutaneous Lichen Planus.
{"title":"Ayurvedic management of a refractory skin disease clinically diagnosed as Cutaneous Lichen Planus—A case report","authors":"Sushma Naranappa Salethoor , Shyamasundaran Kulangara , A.R. Aramya , Rammanohar Puthiyedath","doi":"10.1016/j.jaim.2023.100884","DOIUrl":"https://doi.org/10.1016/j.jaim.2023.100884","url":null,"abstract":"<div><p>This study reports the successful management of a recurrent, refractory skin disease diagnosed clinically as Cutaneous Lichen Planus (CLP) in a female patient with <em>Ayurvedic</em> treatment. A 42-year-old home maker from <em>Coimbatore</em> presented with blackish-red pigmented skin rashes and white streaks. Though mucous membranes were not affected, she did not respond to homoeopathic and biomedical treatment. The lesions were spread all over the body except for the face, scalp, axillary and genital region. In addition, she complained of dry skin, pain, and itching.</p><p>The condition was treated as <em>Kapha-Pitta</em> dominant <em>Tridoshaja Kushta</em> based on <em>Ayurvedic</em> clinical assessment. The patient recovered after one year of conservative <em>Ayurvedic</em> intervention. After six years, there was a relapse, and the patient was admitted for a full course of <em>Ayurvedic</em> treatment and recovered within six months. <em>Ayurvedic</em> interventions should be considered an option in refractory skin diseases like Cutaneous Lichen Planus.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 2","pages":"Article 100884"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947623002012/pdfft?md5=7da889aa6a03451675ed65b6ccf803a8&pid=1-s2.0-S0975947623002012-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140181142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.jaim.2024.100889
K. Shanti , G. Gopinathan
Diplopia or double vision has many aetiologies and often presents to the ophthalmologist. The causes of diplopia may be ocular or neurogenic in origin. Any trauma to the eyes in the form of blow-out fractures causes diplopia by damaging the third nerve. The management by the practitioners of contemporary science depends upon the extent of the nerve or muscle injury. Entrapment of muscles requires surgical intervention, whereas others are managed conservatively. The recovery rate is the least for diplopia of traumatic origin.
A 50-year-old male who sought Ayurvedic treatment for diplopia in the last three months was diagnosed with partial third nerve palsy after a fracture of the left orbit. He underwent Ayurvedic therapy in the form of internal medicines such as Danadanayanadi kashaya, Ksheerabala 101, Vaishwanara churna, and external treatments such as Pratimarsha Nasya, Siro abhyanga, and Tarpana.
At the end of 2 months of Ayurvedic treatment, the patient completely recovered from diplopia.
Ayurvedic treatment effectively resolved diplopia in a short time. Patients can benefit from the same if treated promptly in the early stage itself. However, more extensive studies with larger samples will yield more data to prove the potential of Ayurveda in such cases.
{"title":"Rapid improvement of oculomotor nerve function with ayurvedic treatment in traumatic diplopia - A case report","authors":"K. Shanti , G. Gopinathan","doi":"10.1016/j.jaim.2024.100889","DOIUrl":"https://doi.org/10.1016/j.jaim.2024.100889","url":null,"abstract":"<div><p>Diplopia or double vision has many aetiologies and often presents to the ophthalmologist. The causes of diplopia may be ocular or neurogenic in origin. Any trauma to the eyes in the form of blow-out fractures causes diplopia by damaging the third nerve. The management by the practitioners of contemporary science depends upon the extent of the nerve or muscle injury. Entrapment of muscles requires surgical intervention, whereas others are managed conservatively. The recovery rate is the least for diplopia of traumatic origin.</p><p>A 50-year-old male who sought Ayurvedic treatment for diplopia in the last three months was diagnosed with partial third nerve palsy after a fracture of the left orbit. He underwent Ayurvedic therapy in the form of internal medicines such as <em>Danadanayanadi kashaya, Ksheerabala 101, Vaishwanara churna,</em> and external treatments such as <em>Pratimarsha Nasya, Siro abhyanga, and Tarpana</em>.</p><p>At the end of 2 months of Ayurvedic treatment, the patient completely recovered from diplopia.</p><p>Ayurvedic treatment effectively resolved diplopia in a short time. Patients can benefit from the same if treated promptly in the early stage itself. However, more extensive studies with larger samples will yield more data to prove the potential of Ayurveda in such cases.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 2","pages":"Article 100889"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000044/pdfft?md5=ca6829186210d635b2932abb7caa17b6&pid=1-s2.0-S0975947624000044-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140163992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Major Depressive Disorder (MDD) is one of the common depressive disorder. MDD has high comorbidity and has greater implications on quality of life. Whole system Ayurveda management protocol (WSAP) is explored for it's possible role in management of MDD.
Objective
To evaluate the efficacy of Whole system Ayurveda management protocol on Major Depressive Disorder.
Material and Methods
Study was a randomized controlled trial. Total 50 patients of MDD meeting the DSM V criteria, age group 20–70 years of either sex participated in the study. They were randomly divided into two groups, control group received Escitalopram 10 mg twice a day and Ayurveda group was on WSAP. Interventions were for 60 days. Assessments were done through various clinical parameters like Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HARS), Brief psychiatric rating scale (BPRS), Pittsburgh Sleep Quality Index (PSQI), WHO Quality of Life- BREF (WHOQOL-BREF), Clinical Global Improvement scale (CGI), UKU Side effect scale. Assessments during intervention was on every 15th day.
Results
Study showed that Ayurveda group produced significant outcome improvement compared to control group in HDRS (p = 0.01), HARS (p = 0.03), PSQI (p = 0.03), WHOQOL-Bref (p < 0.001) and UKU side effect scale (p = 0.02). Both the group showed improvements in all the parameters except in WHOQOL-Bref where Ayurveda group only showed improvements (p < 0.001). Effect size showed large effect in WHOQOL-Bref. Mild side effects were reported in control group and none in Ayurveda group.
Conclusion
WSAP was effective in management of MDD and had better side effect profile. Further studies needed.
{"title":"Efficacy of whole system ayurveda management protocol in major depressive disorder- A randomized controlled clinical trial","authors":"Anjali Punia , Sameeran Chate , Basavaraj R. Tubaki , Nagula Himaja","doi":"10.1016/j.jaim.2024.100896","DOIUrl":"https://doi.org/10.1016/j.jaim.2024.100896","url":null,"abstract":"<div><h3>Background</h3><p>Major Depressive Disorder (MDD) is one of the common depressive disorder. MDD has high comorbidity and has greater implications on quality of life. Whole system Ayurveda management protocol <em>(WSAP)</em> is explored for it's possible role in management of MDD.</p></div><div><h3>Objective</h3><p>To evaluate the efficacy of Whole system Ayurveda management protocol on Major Depressive Disorder.</p></div><div><h3>Material and Methods</h3><p>Study was a randomized controlled trial. Total 50 patients of MDD meeting the DSM V criteria, age group 20–70 years of either sex participated in the study. They were randomly divided into two groups, control group received Escitalopram 10 mg twice a day and Ayurveda group was on WSAP. Interventions were for 60 days. Assessments were done through various clinical parameters like Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HARS), Brief psychiatric rating scale (BPRS), Pittsburgh Sleep Quality Index (PSQI), WHO Quality of Life- BREF (WHOQOL-BREF), Clinical Global Improvement scale (CGI), UKU Side effect scale. Assessments during intervention was on every 15th day.</p></div><div><h3>Results</h3><p>Study showed that Ayurveda group produced significant outcome improvement compared to control group in HDRS (p = 0.01), HARS (p = 0.03), PSQI (p = 0.03), WHOQOL-Bref (p < 0.001) and UKU side effect scale (p = 0.02). Both the group showed improvements in all the parameters except in WHOQOL-Bref where Ayurveda group only showed improvements (p < 0.001). Effect size showed large effect in WHOQOL-Bref. Mild side effects were reported in control group and none in Ayurveda group.</p></div><div><h3>Conclusion</h3><p><em>WSAP was</em> effective in management of MDD and had better side effect profile. Further studies needed.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 2","pages":"Article 100896"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000111/pdfft?md5=9930dc45b32d0009e6d09c91cfd6bccc&pid=1-s2.0-S0975947624000111-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140546322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.jaim.2024.100903
Ansul Kumar , Mohd Saif Khan , Zeya Ul Haque , Arpita Rai , Mohammad Fazil , Gulam Rabbani
Background
The pathogenesis of COVID-19 includes an integrated immune-inflammatory response. Modulation of host immune responses against the SARS-CoV-2 virus might be effective therapeutic management. Various Unani formulations have an immunomodulatory effect.
Objective
To explore the immunomodulatory effect and safety of Unani polyherbal drug (Tiryaq Wabai) in COVID-19 patients.
Materials and methods
The current study was a randomized placebo-controlled clinical trial that included 92 mild to moderate COVID-19 patients randomized into two groups. The Unani formulation Tiryaq Wabai (2 gm orally once a day) was used as an intervention for 45 days, while the control group received a placebo. Both groups received standard care treatment. The primary outcome was 50% increment in absolute lymphocyte count (ALC). The secondary outcome was 50% increment in mean lymphocyte percentage, CD4 cells, and CD8 cell count. The mean increase in all the above parameters has also been studied. Relevant statistical tests were used to analyze the effect.
Results
A statistically significant improvement in a 50% increase in ALC (p-value, 0.004), lymphocyte percentage (p-value, 0.056), CD4 (p-value, 0.005), and CD8 cell count (p-value, 0.050) was reported. Also, a significant improvement in the mean value of the lymphocyte percentage (p-value 0.0007), ALC (p-value 0.0022), CD4 cell count (p-value 0.0025), and CD8 cell count (p-value 0.0093) was observed after the treatment. One adverse event of mild grade was reported in the placebo group. The analysis of safety parameters (LFT and KFT) was normal for both groups.
Conclusion
In mild to moderate COVID-19 patients, Tiryaq Wabai effectively showed immunomodulatory activity by improving ALC count, lymphocyte percentage, CD4, and CD8 cell count.
{"title":"Immunomodulatory effect of Unani polyherbal formulation - Tiryaq Wabai in mild to moderate COVID-19 patients – A randomized placebo-controlled clinical trial","authors":"Ansul Kumar , Mohd Saif Khan , Zeya Ul Haque , Arpita Rai , Mohammad Fazil , Gulam Rabbani","doi":"10.1016/j.jaim.2024.100903","DOIUrl":"https://doi.org/10.1016/j.jaim.2024.100903","url":null,"abstract":"<div><h3>Background</h3><p>The pathogenesis of COVID-19 includes an integrated immune-inflammatory response. Modulation of host immune responses against the SARS-CoV-2 virus might be effective therapeutic management. Various Unani formulations have an immunomodulatory effect.</p></div><div><h3>Objective</h3><p>To explore the immunomodulatory effect and safety of Unani polyherbal drug (<em>Tiryaq Wabai</em>) in COVID-19 patients.</p></div><div><h3>Materials and methods</h3><p>The current study was a randomized placebo-controlled clinical trial that included 92 mild to moderate COVID-19 patients randomized into two groups. The Unani formulation <em>Tiryaq Wabai</em> (2 gm orally once a day) was used as an intervention for 45 days, while the control group received a placebo. Both groups received standard care treatment. The primary outcome was 50% increment in absolute lymphocyte count (ALC). The secondary outcome was 50% increment in mean lymphocyte percentage, CD4 cells, and CD8 cell count. The mean increase in all the above parameters has also been studied. Relevant statistical tests were used to analyze the effect.</p></div><div><h3>Results</h3><p>A statistically significant improvement in a 50% increase in ALC (p-value, 0.004), lymphocyte percentage (p-value, 0.056), CD4 (p-value, 0.005), and CD8 cell count (p-value, 0.050) was reported. Also, a significant improvement in the mean value of the lymphocyte percentage (p-value 0.0007), ALC (p-value 0.0022), CD4 cell count (p-value 0.0025), and CD8 cell count (p-value 0.0093) was observed after the treatment. One adverse event of mild grade was reported in the placebo group. The analysis of safety parameters (LFT and KFT) was normal for both groups.</p></div><div><h3>Conclusion</h3><p>In mild to moderate COVID-19 patients, <em>Tiryaq Wabai</em> effectively showed immunomodulatory activity by improving ALC count, lymphocyte percentage, CD4, and CD8 cell count.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 2","pages":"Article 100903"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000184/pdfft?md5=8e7c984385b2056c4a79ca79734677e7&pid=1-s2.0-S0975947624000184-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140344488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.1016/j.jaim.2024.100927
Ashok D.B. Vaidya, Rama Vaidya
{"title":"Corrigendum to “A century of ‘The science of yoga’ (1921–2021): Revival, renewal and renaissance” [J. Ayurveda Integr. Med. 14 (2023) 100613]","authors":"Ashok D.B. Vaidya, Rama Vaidya","doi":"10.1016/j.jaim.2024.100927","DOIUrl":"https://doi.org/10.1016/j.jaim.2024.100927","url":null,"abstract":"","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 2","pages":"Article 100927"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947624000421/pdfft?md5=2cecf69e74ea319216052ea0346e4fd1&pid=1-s2.0-S0975947624000421-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140647455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study aimed at investigating whether the duration of fermenting Panchagavya (PG) preparation in copper vessel affects its biological activity and microbiome composition.
Materials and methods
Prophylactic potential of PG against bacterial infection was assessed through an in vivo assay employing the nematode worm Caenorhabditis elegans as a model host. Bacterial diversity of the PG samples was revealed through metagenomic analysis.
Results
Duration of fermentation was found to affect biological activity as well as microbiome composition of the PG samples. PG-samples fermented ≥60 min lost their prophylactic potential, and develop anthelmintic activity. Bacterial phyla whose relative abundance was significantly different between the prophylactic and anthelmintic PG samples were Planctomycetota, Proteabacteria, Bacteroidota, Verrucomicrobiota, Patescibacteria, Acidobacteriota, Chloroflexi, Firmicutes and Campilobacterota.
Conclusion
This study validates the prophylactic potential of Panchagavya against bacterial pathogens, and shows that duration of the fermentation time while preparing PG can have profound effect on its biological activities. Biological activities of PG samples seem to have a correlation with their inherent microbial community. Metagenomic profiling can be an effective tool for standardization of PG formulations.
{"title":"Duration of fermentation affects microbiome composition and biological activity of an Indian traditional formulation – Panchagavya","authors":"Gemini Gajera , Snehal Funde , Hanmanthrao Palep , Vijay Kothari","doi":"10.1016/j.jaim.2023.100880","DOIUrl":"https://doi.org/10.1016/j.jaim.2023.100880","url":null,"abstract":"<div><h3>Objective</h3><p>This study aimed at investigating whether the duration of fermenting <em>Panchagavya</em> (PG) preparation in copper vessel affects its biological activity and microbiome composition.</p></div><div><h3>Materials and methods</h3><p>Prophylactic potential of PG against bacterial infection was assessed through an <em>in vivo</em> assay employing the nematode worm <em>Caenorhabditis elegans</em> as a model host. Bacterial diversity of the PG samples was revealed through metagenomic analysis.</p></div><div><h3>Results</h3><p>Duration of fermentation was found to affect biological activity as well as microbiome composition of the PG samples. PG-samples fermented ≥60 min lost their prophylactic potential, and develop anthelmintic activity. Bacterial phyla whose relative abundance was significantly different between the prophylactic and anthelmintic PG samples were Planctomycetota, Proteabacteria, Bacteroidota, Verrucomicrobiota, Patescibacteria, Acidobacteriota, Chloroflexi, Firmicutes and Campilobacterota.</p></div><div><h3>Conclusion</h3><p>This study validates the prophylactic potential of <em>Panchagavya</em> against bacterial pathogens, and shows that duration of the fermentation time while preparing PG can have profound effect on its biological activities. Biological activities of PG samples seem to have a correlation with their inherent microbial community. Metagenomic profiling can be an effective tool for standardization of PG formulations.</p></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"15 2","pages":"Article 100880"},"PeriodicalIF":2.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0975947623001973/pdfft?md5=724a8b8030c76d6908fe07a69da2ae9f&pid=1-s2.0-S0975947623001973-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140062487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}